AMPE (Ampio Pharmaceuticals) Accumulated Depreciation: $0.00 Mil (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ampio Pharmaceuticals Accumulated Depreciation?

Ampio Pharmaceuticals AMPE -71.39% Accumulated Depreciation is $0.00 Mil as of Dec. 2023.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Ampio Pharmaceuticals's annual accumulated depreciation increased from Dec. 2021 ($-8.23 Mil) to Dec. 2022 ($-9.25 Mil) but then stayed the same from Dec. 2022 ($-9.25 Mil) to Dec. 2023 ($0.00 Mil).

Ampio Pharmaceuticals Accumulated Depreciation Related Terms

Ampio Pharmaceuticals Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Ampio Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ampio Pharmaceuticals Accumulated Depreciation Chart

Ampio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -8.23 -9.25 0.00

Ampio Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.25 0.00 0.00 0.00 0.00

Ampio Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $0.00 Mil mean?
Ampio Pharmaceuticals (AMPE) has a Accumulated Depreciation of $0.00 Mil as of Dec. 2023. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ampio Pharmaceuticals and its competitors.
Is Ampio Pharmaceuticals' Accumulated Depreciation too high?
Ampio Pharmaceuticals' current Accumulated Depreciation is $0.00 Mil.
How does Ampio Pharmaceuticals' Accumulated Depreciation compare to EFTR and VBIVQ?
Ampio Pharmaceuticals' Accumulated Depreciation of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ampio Pharmaceuticals and its competitors. Ampio Pharmaceuticals's current Accumulated Depreciation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ampio Pharmaceuticals stock overvalued right now?
Ampio Pharmaceuticals (AMPE) has a current Accumulated Depreciation of $0.00 Mil. The current Accumulated Depreciation is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Ampio Pharmaceuticals (AMPE), the current Accumulated Depreciation is $0.00 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ampio Pharmaceuticals Business Description

Address 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201).